HealthDay on MSN20m
FDA Approves TNKase for Acute Ischemic StrokeThe U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...
Topline Results for Phase 2b PROGRESS Study of Pilavapadin (LX9211) in Diabetic Peripheral Neuropathic Pain (DPNP); 10 mg dose to Advance i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback